Security · CUSIP 00182CAC7
ANI PHARMACEUTICALS INC
NOTE 2.250% 9/0 · institutional ownership from 13F filings
13F holders
4
Shares held
16.3M
Value held
$44.2M
New / sold out
1 / 0
Added / reduced
2 / 0
net +4.2M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q4 2025
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| Boussard & Gavaudan Investment Management LLP | 18,500 | $23.6M | 3.66% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 11,473,000 | $14.5M | 1.65% |
| PICTON MAHONEY ASSET MANAGEMENT | 4,000,000 | $5.0M | 0.04% |
| Bank of New York Mellon Corp | 850,000 | $1.1M | 0.00% |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| PICTON MAHONEY ASSET MANAGEMENT | New | +4,000,000 | – |
| Bank of New York Mellon Corp | Added | +150,000 | +21.4% |
| Boussard & Gavaudan Investment Management LLP | Added | +8,500 | +85.0% |
Biggest sellers
Nothing to show.